S12 – Rapid Fire: Retina


Prof Mark Gillies; Dr Thomas Edwards; A/Prof Masayuki Ohnaka; Dr Jacob Cook; Dr Chi Yun Doreen Ho; Prof Paul Mitchell; Dr Samuel McLenachan; Prof Colin Green; Dr Ross Littlewood; Dr Sarah Wang

SKU: RANZCO2017-S12 Category:


Topics and Speakers:
Comparison of Ranibizumab and Aflibercept in Patients with
Neovascular Age-Related Macular Degeneration treated following a
‘Treat and Extend’ protocol: efficacy variables from the pre-specified
12-month interim analysis of the RIVAL study – Prof Mark Gillies
Sub-retinal chip implantation to partially restore vision in advanced
retinitis pigmentosa: update from the Oxford Retinal Implant Alpha
AMS Trial – Dr Thomas Edwards
Randomised, Open-Label Study to Evaluate 2 Intravitreal Aflibercept
Treat-and-Extend Dosing Regimens in Wet Age-Related Macular
Degeneration: 52-Week Outcomes from ALTAIR
– A/Prof Masayuki Ohnaka
The Effectiveness of Triamcinolone in Combination with Anti-VEGF
in Treatment Resistant Wet Age Related Macular Degeneration; A
Retrospective Observational Study – Dr Jacob Cook
Reticular pseudodrusen and its relationship with choroidal thickness in
intermediate age-related macular degeneration
– Dr Chi Yun Doreen Ho
Intravitreal Aflibercept (IVT-AFL) With and Without Photodynamic
Therapy (PDT) in Polypoidal Choroidal Vasculopathy (PCV):
Anatomical Outcomes Assessed by Optical Coherence Tomography
(OCT) in the PLANET Study – Prof Paul Mitchell
A novel CLN3 mutation associated with late onset retinal degeneration
causes accumulation of mitochondrial ATPase
subunit C – Dr Samuel McLenachan
Targeting the inflammasome pathway in retinal disease – an oral
treatment for AMD – Prof Colin Green
The C test for tritan discrimination – normative data analysis
– Dr Ross Littlewood
A spectrum of retinal vasculature measures and coronary artery
disease – Dr Sarah Wang

49th Annual Scientific Congress of The Royal Australian and New Zealand College of Ophthalmologists

Additional information